Kyle Bonner, in Allenwood, NJ - Social Worker

Kyle Bonner, is a Social Worker - Clinical based in Allenwood, New Jersey. Kyle Bonner is licensed to practice in New Jersey (license number 44SC05758300) and his current practice location is 2209 Ramshorn Dr, Allenwood, New Jersey. He can be reached at his office (for appointments etc.) via phone at (732) 850-1348.

NPI number for Kyle Bonner is 1245722438 and his current mailing address is 2209 Ramshorn Dr, Allenwood, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1245722438.

Contact Information

	Kyle Bonner,
	2209 Ramshorn Dr, Allenwood, NJ 08720-7025
	(732) 850-1348
	Not Available

Healthcare Provider's Profile

Full Name	Kyle Bonner
Gender	Male
Speciality	Social Worker - Clinical
Location	2209 Ramshorn Dr, Allenwood, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1245722438
Provider Enumeration Date: 06/04/2018
Last Update Date: 02/11/2021

Medical Identifiers

Medical identifiers for Kyle Bonner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245722438	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	44SC05758300 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kyle Bonner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kyle Bonner, 2209 Ramshorn Dr, Allenwood, NJ 08720-7025 Ph: () -	Kyle Bonner, 2209 Ramshorn Dr, Allenwood, NJ 08720-7025 Ph: (732) 850-1348

News Archive

Calif. insurers opt to resume kids' policies; Meanwhile, other plans cut mental health benefits in response to health law

Some California insurers have decided to resume offering children's individual health insurance policies — a step that reverses decisions made last fall to exit this market. Meanwhile, The Wall Street Journal reports that, as a result of requirements in the new health law, some health plans are opting to cut mental health benefits.

Roundup: Mass. voters to consider 'right-to-die'; Texas Planned Parenthood hearing contentious; Calif. kids' palliative care

On Election Day, voters in the Bay State will consider whether to approve the "Death With Dignity Act," a measure that would make Massachusetts just the third state in the country to formally approve physician-assisted suicide. The proposal, identified as Question 2 on the ballot, is nearly identical to laws passed in Oregon in 1994 and in Washington in 2008. But the politics is very different. The looming vote has split the state's medical community and mobilized opposition from the politically powerful Catholic Church.

Patent office ruling in favor of Neuralstem leads to stay of Stemcells Inc. lawsuit

Neuralstem Inc. has announced that StemCells Inc. has consented to a stay of the lawsuit it filed against Neuralstem in August 2006.

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

AstraZeneca and Merck, known as MSD outside the U.S. and Canada, today announced that the European Medicines Agency (EMA) has granted orphan designation to selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).

Kyle Bonner, - Clinical Social Worker in Allenwood, NJ